Literature DB >> 10915066

Varicella mortality: trends before vaccine licensure in the United States, 1970-1994.

P A Meyer1, J F Seward, A O Jumaan, M Wharton.   

Abstract

We examined varicella deaths in the United States during the 25 years before vaccine licensure and identified 2262 people who died with varicella as the underlying cause of death. From 1970 to 1994, varicella mortality declined, followed by an increase. Mortality rates were highest among children; however, adult varicella deaths more than doubled in number, proportion, and rate per million population. Despite declining fatality rates, in 1990-1994, adults had a risk 25 times greater and infants had a risk 4 times greater of dying from varicella than did children 1-4 years old, and most people who died of varicella were previously healthy. Varicella deaths are now preventable by vaccine. Investigation and reporting of all varicella deaths in the United States is needed to accurately document deaths due to varicella, to improve prevention efforts, and to evaluate the vaccine's impact on mortality.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10915066     DOI: 10.1086/315714

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  60 in total

1.  Chickenpox vaccination, not chickenpox, should be routine for Canadian children.

Authors:  B J Law
Journal:  CMAJ       Date:  2001-05-15       Impact factor: 8.262

2.  Tracking varicella deaths: accuracy and completeness of death certificates and hospital discharge records, New York State, 1989-1995.

Authors:  Karin Galil; Mark J Pletcher; Barbara J Wallace; Jane Seward; Pamela A Meyer; Andrew L Baughman; Melinda Wharton
Journal:  Am J Public Health       Date:  2002-08       Impact factor: 9.308

3.  Routine immunization of adults in Canada: Review of the epidemiology of vaccine-preventable diseases and current recommendations for primary prevention.

Authors:  Michael D Parkins; Shelly A McNeil; Kevin B Laupland
Journal:  Can J Infect Dis Med Microbiol       Date:  2009       Impact factor: 2.471

4.  Varicella vaccine safety and immunogenicity in patients with juvenile rheumatic diseases receiving methotrexate and corticosteroids.

Authors:  Robert W Frenck; Jane F Seward
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-07       Impact factor: 4.794

5.  Control of varicella disease, version 2.0.

Authors:  David W Kimberlin
Journal:  J Infect Dis       Date:  2011-02-01       Impact factor: 5.226

6.  Primary varicella in an immunocompetent adult.

Authors:  Izikson Leonid; Lilly Evelyn
Journal:  J Clin Aesthet Dermatol       Date:  2009-08

7.  Prevalence of anti-varicella-zoster virus antibodies in French infants under 15 months of age.

Authors:  Didier Pinquier; Arnaud Gagneur; Laurent Balu; Olivier Brissaud; Christèle Gras Le Guen; Isabelle Hau-Rainsard; Olivier Mory; Georges Picherot; Loïc De Pontual; Jean-Louis Stephan; Peter Maple; Judith Breuer; Marie Aubert; Evelyne Caulin; Claudine Sana; Pierre Pradat; Benoît Soubeyrand; Philippe Reinert
Journal:  Clin Vaccine Immunol       Date:  2009-01-28

8.  Severe complications of chickenpox in hospitalised children in the UK and Ireland.

Authors:  J C Cameron; G Allan; F Johnston; A Finn; P T Heath; R Booy
Journal:  Arch Dis Child       Date:  2007-11-08       Impact factor: 3.791

9.  Varicella vaccination in Italy : an economic evaluation of different scenarios.

Authors:  Laurent Coudeville; Alain Brunot; Carlo Giaquinto; Carlo Lucioni; Benoit Dervaux
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

Review 10.  Microbiology laboratory and the management of mother-child varicella-zoster virus infection.

Authors:  Massimo De Paschale; Pierangelo Clerici
Journal:  World J Virol       Date:  2016-08-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.